Contact
Please use this form to send email to PR contact of this press release:
Ultragenyx Provides Regulatory Update on Burosumab (KRN23)
TO:
Please use this form to send email to PR contact of this press release:
Ultragenyx Provides Regulatory Update on Burosumab (KRN23)
TO: